Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Santa Rosa CA, Hartford CT, Washington D.C. DC,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase1, Recruiting
Active & Responsive
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT05723107
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
for
Pancreatic Neoplasms
Location: Norwalk CT
Sponsor: Nuvance Health
Sex: All
Age: 50 - 70+
Code: NCT03250078
Recruiting
Active & Responsive
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors